121 related articles for article (PubMed ID: 11214919)
21. Early detection of prion protein aggregation with a fluorescent pentameric oligothiophene probe using spectral confocal microscopy.
Stepanchuk A; Tahir W; Nilsson KPR; Schatzl HM; Stys PK
J Neurochem; 2021 Mar; 156(6):1033-1048. PubMed ID: 32799317
[TBL] [Abstract][Full Text] [Related]
22. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases.
Schmitz M; Cramm M; Llorens F; Müller-Cramm D; Collins S; Atarashi R; Satoh K; Orrù CD; Groveman BR; Zafar S; Schulz-Schaeffer WJ; Caughey B; Zerr I
Nat Protoc; 2016 Nov; 11(11):2233-2242. PubMed ID: 27735933
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of a protein misfolding cyclic amplification for PrPSc].
Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
[TBL] [Abstract][Full Text] [Related]
24. Eight prion strains have PrP(Sc) molecules with different conformations.
Safar J; Wille H; Itri V; Groth D; Serban H; Torchia M; Cohen FE; Prusiner SB
Nat Med; 1998 Oct; 4(10):1157-65. PubMed ID: 9771749
[TBL] [Abstract][Full Text] [Related]
25. Prion Diagnosis: Application of Real-Time Quaking-Induced Conversion.
Kang HE; Mo Y; Abd Rahim R; Lee HM; Ryou C
Biomed Res Int; 2017; 2017():5413936. PubMed ID: 28596963
[TBL] [Abstract][Full Text] [Related]
26. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Saborio GP; Permanne B; Soto C
Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
[TBL] [Abstract][Full Text] [Related]
27. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.
Neisser-Svae A; Bailey A; Gregori L; Heger A; Jordan S; Behizad M; Reichl H; Römisch J; Svae TE
Vox Sang; 2009 Oct; 97(3):226-33. PubMed ID: 19548963
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
29. Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions.
Imberdis T; Ayrolles-Torro A; Verdier JM; Perrier V
Curr Top Med Chem; 2013; 13(19):2477-83. PubMed ID: 24059332
[TBL] [Abstract][Full Text] [Related]
30. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity.
Bellon A; Seyfert-Brandt W; Lang W; Baron H; Gröner A; Vey M
J Gen Virol; 2003 Jul; 84(Pt 7):1921-1925. PubMed ID: 12810888
[TBL] [Abstract][Full Text] [Related]
31. Molecular diagnostic tools in Creutzfeldt-Jakob disease and other prion disorders.
Van Everbroeck B; Boons J; De Leenheir E; Lübke U; Cras P
Expert Rev Mol Diagn; 2004 May; 4(3):351-9. PubMed ID: 15137902
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel fluorescent probes preventing PrP
Zaccagnini L; Brogi S; Brindisi M; Gemma S; Chemi G; Legname G; Campiani G; Butini S
Eur J Med Chem; 2017 Feb; 127():859-873. PubMed ID: 27842893
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
34. Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting.
Kuczius T; Brinkmann B; Grassi J
Neurochem Int; 2007 Jan; 50(1):102-8. PubMed ID: 16962685
[TBL] [Abstract][Full Text] [Related]
35. Detection of prion protein immune complex for bovine spongiform encephalopathy diagnosis using fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy.
Fujii F; Horiuchi M; Ueno M; Sakata H; Nagao I; Tamura M; Kinjo M
Anal Biochem; 2007 Nov; 370(2):131-41. PubMed ID: 17825783
[TBL] [Abstract][Full Text] [Related]
36. Sensitive detection of aggregated prion protein via proximity ligation.
Hammond M; Wik L; Deslys JP; Comoy E; Linné T; Landegren U; Kamali-Moghaddam M
Prion; 2014; 8(3):261-5. PubMed ID: 25482604
[TBL] [Abstract][Full Text] [Related]
37. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
38. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease.
Head MW; Northcott V; Rennison K; Ritchie D; McCardle L; Bunn TJ; McLennan NF; Ironside JW; Tullo AB; Bonshek RE
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):342-6. PubMed ID: 12506094
[TBL] [Abstract][Full Text] [Related]
39. [Prion disease].
Mizusawa H
Rinsho Shinkeigaku; 2010 Nov; 50(11):797-802. PubMed ID: 21921445
[TBL] [Abstract][Full Text] [Related]
40. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
Prion; 2015; 9(5):394-403. PubMed ID: 26555211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
